about
Clinical significance of hepatitis B surface antigen mutantsVertical transmission of hepatitis B virus: challenges and solutionsEpidemiology of acute and chronic hepatitis B and delta over the last 5 decades in ItalyPrevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study.Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective studyInterferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B.Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection.Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus.Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.Hepatitis B virus infection in children.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations.Molecular docking studies of phytochemicals from Phyllanthus niruri against Hepatitis B DNA Polymerase.Tenofovir and its potential in the treatment of hepatitis B virus.Clinical features of adverse reactions associated with telbivudine.Telbivudine myopathy in a patient with chronic hepatitis B.
P2860
Q26773676-960A36C8-9FB9-4C73-AB23-6D47D658AD30Q33774099-00BE67CD-F608-45DB-AE35-116D00075285Q33801300-C717AFF5-FE0F-4F5F-833A-30A175CD0050Q33847643-FCE23DFA-2143-47CB-977F-82B25002CE00Q33958876-15AD0EC8-00C1-488D-A350-C6A5A627750FQ34424151-DC8C2EDF-94E6-412A-9A1E-0556A8A3C420Q36492609-9EB969F2-1AF3-4AB9-884D-B49BBAB90F05Q37945752-44EA29A9-A9B9-4D93-AD1B-007FC15E12A6Q38193198-2F2E4645-5B63-4747-BB0C-1C8BEE70FBD5Q38212793-9EC0B956-AD3B-4BF5-A64D-8F057C587E11Q38233860-81A5CB12-346B-4A00-8716-D4BE9ED9896DQ38365905-0DE5032F-1FE2-4E5C-A92D-89D45790F09BQ38793776-D91F1A4D-DD8E-4286-B974-956FA2B3F4A2Q40454877-7C188CC3-960F-4526-8C50-9FF78ED6113DQ40925649-E3E11887-D158-4586-A4B0-0D897FC3D869Q41435482-3B6538A5-490E-4912-8568-9787D0D69EC9Q41787869-7C7076CB-AB05-4242-B74F-FBC30BAF003AQ54515456-97398748-C8A8-4422-BF9B-523AB16221BF
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Treating chronic hepatitis B: today and tomorrow.
@ast
Treating chronic hepatitis B: today and tomorrow.
@en
type
label
Treating chronic hepatitis B: today and tomorrow.
@ast
Treating chronic hepatitis B: today and tomorrow.
@en
prefLabel
Treating chronic hepatitis B: today and tomorrow.
@ast
Treating chronic hepatitis B: today and tomorrow.
@en
P1476
Treating chronic hepatitis B: today and tomorrow.
@en
P2093
P304
P356
10.2174/092986706778521995
P577
2006-01-01T00:00:00Z